Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $34.05 Analyst target: $39.12 Upside: 14.89%
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.
See the full interactive analysis & chart →Informational only — not investment advice.